BRAF and neoplasm: This systematic review and meta‐analysis of mutation prevalence by tumor location among mCRC patients identified a significant difference in prevalence of both KRAS and BRAF mutations by tumor location, with mutations more frequent among right‐sided colon cancers than left‐sided tumors.